{
    "nctId": "NCT00353483",
    "briefTitle": "Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells",
    "officialTitle": "Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Neoplasms",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 300,
    "primaryOutcomeMeasure": "Characterize tumor markers expressed by DTC which are present after systemic therapy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Recently diagnosed with clinical stage II, III, or IV breast cancer\n* Planning to undergo neoadjuvant or adjuvant systemic therapy; patients who have already completed neoadjuvant systemic therapy are also eligible\n* Must be \\>= 18 years of age\n* If female, must not be pregnant\n* Must not have Hepatitis B, C, or HIV\n* Must be willing and able to sign informed consent document",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}